1.
Hematol Oncol
; 39(5): 712-714, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1378932
Subject(s)
Antibodies, Viral/immunology , Antibody Formation/drug effects , COVID-19 Vaccines/administration & dosage , COVID-19/immunology , Leukemia, Lymphocytic, Chronic, B-Cell/immunology , SARS-CoV-2/immunology , Vaccination/methods , Aged , Antibodies, Viral/blood , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , COVID-19/prevention & control , COVID-19/virology , COVID-19 Vaccines/immunology , Female , Follow-Up Studies , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/blood , Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell/virology , Male , Prognosis
2.
Hematol Oncol
; 39(4): 570-574, 2021 Oct.
Article
in English
| MEDLINE | ID: covidwho-1308967
Subject(s)
COVID-19/complications , Leukemia, Lymphocytic, Chronic, B-Cell/therapy , SARS-CoV-2/immunology , Vaccination/methods , Aged , COVID-19/prevention & control , COVID-19/transmission , COVID-19/virology , Disease Management , Female , Humans , Italy/epidemiology , Leukemia, Lymphocytic, Chronic, B-Cell/epidemiology , Leukemia, Lymphocytic, Chronic, B-Cell/virology , Male , Middle Aged , Prognosis , Time Factors
3.
Blood
; 136(6): 763-766, 2020 08 06.
Article
in English
| MEDLINE | ID: covidwho-608216